Statistics
Publications
9
Citations
471
H-Index
9
Active since
1985
Affiliations
Christopher Jackson is an author at Yale University specializing in oncology, medicine, and targeted cancer therapy.
Publications per year
1985–2020
9
9
Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma
Young-Eun Seo, Hee‐Won Suh, Raman Bahal et al. · Biomaterials · 2019 · 117 citations · Full text
Medicine, Cancer Biology, Oncology +14
Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
Christopher Jackson, Seth Noorbakhsh, Ranjini K. Sundaram et al. · Cancer Research · 2019 · 93 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 9